SCHEMBL23129649

SCHEMBL23129649

CC(=O)NC1Cc2cc(Cl)c(Cl)c(C(=O)OCOC(=O)C(C)(C)C)c2OB1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17347841 1.00 — —
SCHEMBL23129960 0.91 — —
SCHEMBL17347826 0.91 — —
SCHEMBL23130290 0.89 MTNR1A (0.30) —
SCHEMBL17347691 0.89 MTNR1A (0.30) —
SCHEMBL23129980 0.88 POLB (0.30) —
SCHEMBL17347814 0.88 POLB (0.30) —
SCHEMBL17347820 0.86 OPRK1 (0.34) —
SCHEMBL23130252 0.86 OPRK1 (0.34) —
SCHEMBL17347844 0.85 PRKCB (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154989-B1 BETA-LACTAMASE INHIBITORS VENATORX PHARMACEUTICALS INC (US) 2021-03-24 — — EP disclosed
Send feedback